Latest News and Press Releases
Want to stay updated on the latest news?
-
HAMILTON, Bermuda, July 28, 2014 (GLOBE NEWSWIRE) -- Seadrill Limited ("Seadrill" or the "Company") is pleased to announce that holders of US$648.6 million of principal amount of Seadrill's...
-
JERSEY, CHANNEL ISLANDS--(Marketwired - Jul 28, 2014) - Randgold Resources' (LSE: RRS) (NASDAQ: GOLD) Tongon gold mine in Côte d'Ivoire is continuing to make headway in its drive to overcome...
-
Hamilton, Bermuda, July 28, 2014 - Seadrill Limited ("Seadrill" or the "Company") is pleased to announce that holders of US$648.6 million of principal amount of Seadrill's convertible bonds due 2017...
-
Presentation of the report for the first half of the fiscal year 2014: Date: Monday August 18th 2014 / kl. 16:00 Venue: Online Presentation Topic: C-RAD Half Year...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} As a result of the Millennium bcp (MBCP) EUR 2.25...
-
OUTOTEC OYJ STOCK EXCHANGE RELEASE JULY 28, 2014 at 9.30 Outotec lowers its financial guidance for 2014 and publishes order intake for Q2 Outotec lowers its sales and operating profit margin...
-
Company Announcement no. 17/2014 To: NASDAQ OMX Copenhagen A/S ...
-
On 18 February, PANDORA initiated a share buy-back programme, cf. Company announcement no. 143. The programme is implemented in accordance with the provisions of European Commission Regulation no....
-
The phase II COSMOS study evaluated the interferon-free combination of simeprevir and sofosbuvir in treatment-naïve and prior null-responder patients with all stages of liver fibrosis, including...
-
Fas II-studien COSMOS utvärderade den interferonfria kombinationen av simeprevir och sofosbuvir i behandlingsnaiva patienter och patienter som inte svarat på tidigare behandling. Studien inkluderade...